Boston Partners
PCRX icon

Boston Partners’s Pacira BioSciences PCRX Stock Holding History

Boston Partners’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-29,977
Closed -$858K – 748
2024
Q2 		$858K Buy
29,977
+8,907
+42% +$254K ﹤0.01% 609
2024
Q1 		$616K Sell
21,070
-36,748
-64% -$1.13M ﹤0.01% 660
2023
Q4 		$1.95M Sell
57,818
-50,691
-47% -$1.48M ﹤0.01% 502
2023
Q3 		$3.33M Buy
108,509
+55,679
+105% +$2.01M ﹤0.01% 441
2023
Q2 		$2.12M Sell
52,830
-24,880
-32% -$1.03M ﹤0.01% 474
2023
Q1 		$3.17M Buy
77,710
+156
+0.2% +$6.21K ﹤0.01% 429
2022
Q4 		$2.99M Sell
77,554
-23,035
-23% -$1.12M ﹤0.01% 419
2022
Q3 		$5.35M Buy
100,589
+56,282
+127% +$3.13M 0.01% 388
2022
Q2 		$2.58M Buy
44,307
+362
+0.8% +$23.7K ﹤0.01% 419
2022
Q1 		$3.35M Buy
43,945
+32,351
+279% +$2.16M ﹤0.01% 419
2021
Q4 		$698K Buy
+11,594
New +$639K ﹤0.01% 577

Other funds holding PCRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $34.9B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return